51171823 Granisetron

Definition

UNSPSC 51171823

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C18H24N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WZG3J2MCOL, chemically known as 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo- but generally known as granisetron, which bears US NIH Compound Identifier 3510. European Medicines Agency schedules Granisetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07964MIG. The term GRANISETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules granisetron in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule granisetron under HS 29399900 and SITC 54149. As of Q4 2014, GRANISETRON remains the US FDA Preferred Term for this commodity. Granisetron bears US NLM identifiers UMLS ID C0061863 and NCI Concept Code C62031. SMILES: O=C(NC1CC2N(C(C1)CCC2)C)C1NN(C2C1CCCC2)C.

Same parent

Under 51171800 · 49

51171805 Trimethobenzamide Commodity 51171806 Metoclopramide Commodity 51171807 Cinnarizine Commodity 51171808 Difenidol or diphenidol Commodity 51171809 Cyclizine Commodity 51171811 Combinational fructose dextrose and phosphoric acid Commodity 51171812 Prochlorperazine Commodity 51171813 Metopimazine Commodity 51171814 Dolasetron Commodity 51171816 Ondansetron Commodity 51171819 Thiethylperazine Commodity 51171820 Dimenhydrinate Commodity 51171822 Palonosetron Commodity 51171823 Granisetron You are here 51171824 Bemesetron Commodity 51171825 Acotiamide Commodity 51171826 Alepride Commodity 51171827 Alizapride Commodity 51171828 Azasetron Commodity 51171829 Azasetron hydrochloride Commodity 51171830 Batanopride Commodity 51171831 Cipropride Commodity 51171832 Benzquinamide Commodity 51171833 Bromopride Commodity 51171834 Cannabinol or nabiximols or tetrahydrocannabinol Commodity 51171835 Casopitant Commodity 51171836 Cilansetron Commodity 51171837 Flumeridone Commodity 51171838 Fosaprepitant or ivemend Commodity 51171839 Hydroxyzine Commodity 51171840 Hyoscine or levo-duboisine or scopolamine Commodity 51171841 Iprozilamine Commodity 51171842 Denipride Commodity 51171843 Maropitant Commodity 51171844 Nabilone Commodity 51171845 Nantradol Commodity 51171846 Nonabine Commodity 51171847 Pancopride Commodity 51171848 Pipamazine Commodity 51171849 Levonantradol Commodity 51171850 Prochlorperazine mesilate Commodity 51171851 Ricasetron Commodity 51171852 Tinisulpride Commodity 51171853 Tropisetron Commodity 51171854 Ramosetron Commodity 51171855 Clebopride Commodity 51171856 Acetylleucine Commodity 51171857 Fludorex Commodity 51171858 Netupitant/Palonosetron Commodity

Activities that produce or sell this

KBLI · 9

Inherited from family 51170000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47111 Perdagangan Eceran Berbagai Macam Barang yang Utamanya Makanan, Minuman, atau Tembakau dengan Sistem Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class